BioSpace News Archive

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its second quarter 2020 operating results on Tuesday, August 4, 2020 after market close

POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today provided a corporate update and announced its cash position and revenue for the second quarter and first half of 2020.

AbSci, a growth-stage synthetic biology company whose Protein Printing™ technology enables rapid and low-cost biomanufacturing of difficult-to-produce biotherapeutics, today announced that it has entered into an agreement to license its E. coli SoluPro® protein expression technology to Alpha Cancer Technologies for the production of Recombinant Human Alpha-fetoprotein (hAFP).

Agriculture may now have another solution to positively impact climate change thanks to a new initiative launched by Bayer.

Profound Medical Corp. is pleased to announce that it has closed its previously-announced underwritten offering of common shares of the Company at a price of US$14.50 per Common Share.

Genetics Institute of America announced today that it has received IRB approval to expand its Prostate Cancer Study (GH215) to include: Breast, Ovarian and Lung Cancers.

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - PEA-PME eligible), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces preliminary consolidated revenues for the half year ending June 30, 2020.

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that it will release its second quarter 2020 financial and operational results and host a conference call and live webcast on Thursday, August 6, 2020.

Elizabeth Lee-Lewandrowski, Ph.D., MPH, a national key opinion leader on tick-borne diseases, will discuss the findings of a national seven-year study on Lyme disease testing on a webinar she will be conducting on Thursday, July 30.

Shockwave Medical, Inc. announced it will report financial results for the second quarter 2020 after market close on Tuesday, August 11, 2020.